Empaxo 25mg Tablet

Empaxo 25mg Tablet is a medication that contains the active ingredient Empagliflozin. Empagliflozin is classified as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is prescribed for the management of type 2 diabetes mellitus to help control blood sugar levels.

Uses:

Empaxo 25mg Tablet is indicated for the treatment of type 2 diabetes mellitus. It works by inhibiting SGLT2, a protein responsible for the reabsorption of glucose in the kidneys. By reducing glucose reabsorption, Empagliflozin increases the excretion of glucose in the urine, leading to lower blood sugar levels.

Side Effects:

Common side effects may include urinary tract infections, increased urination, and genital yeast infections. Dehydration and low blood pressure may occur. Serious side effects are rare but may include ketoacidosis. Report any unusual or severe side effects to your healthcare provider.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, especially kidney problems or a history of urinary tract infections.
• Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
• Monitor for signs of dehydration, particularly if there are episodes of vomiting or diarrhea.

When Not to Use:

Empaxo 25mg Tablet may not be suitable for use in the following situations:

• Known hypersensitivity or allergy to Empagliflozin or any components of the medication.
• Severe renal impairment or end-stage renal disease.
• History of ketoacidosis or diabetic ketoacidosis.